CHEMOURS CO/THE (CC) Forecast, Price Target & Analyst Ratings
NYSE:CC • US1638511089
16.75 USD
-0.78 (-4.45%)
At close: Mar 5, 2026
16.75 USD
0 (0%)
After Hours: 3/5/2026, 5:36:57 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CHEMOURS CO/THE (CC).
Forecast Snapshot
Consensus Price Target
$19.00
+ 13.42% Upside
Next Earnings Forecast
Release DateMay 4, 2026
PeriodQ1 / 2026
EPS Estimate-$0.03
Revenue Estimate1.44B
ChartMill Buy Consensus
75.56%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$19.00
Upside
+ 13.42%
From current price of $16.75 to mean target of $19.00, Based on 18 analyst forecasts
Low
$14.14
Median
$18.36
High
$24.15
Price Target Revisions
1 Month
18.88%
3 Months
15.50%
Price Target Summary
18 analysts have analysed CC and the average price target is 19 USD. This implies a price increase of 13.42% is expected in the next year compared to the current price of 16.75.
The average price target has been revised upward by 15.5% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
75.56%
CC was analyzed by 18 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about CC.
In the previous month the buy percentage consensus was at a similar level.
CC was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-05 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-02-25 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2026-02-23 | BMO Capital | Maintains | Outperform -> Outperform |
| 2026-02-23 | UBS | Maintains | Buy -> Buy |
| 2026-02-23 | JP Morgan | Maintains | Neutral -> Neutral |
| 2026-02-23 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-21 | Truist Securities | Maintains | Buy -> Buy |
| 2025-12-03 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-11 | UBS | Maintains | Buy -> Buy |
| 2025-11-10 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-10 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-16 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-10-06 | UBS | Maintains | Buy -> Buy |
| 2025-09-23 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-09-16 | Truist Securities | Maintains | Buy -> Buy |
| 2025-07-15 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-07-03 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-05-28 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-14 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-05-12 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-05-07 | UBS | Maintains | Buy -> Buy |
| 2025-04-14 | Truist Securities | Maintains | Buy -> Buy |
| 2025-04-01 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-03-27 | Mizuho | Upgrade | Neutral -> Outperform |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 4, 2026
PeriodQ1 / 2026
EPS Estimate-$0.03
Revenue Estimate1.44B
Revenue Q2Q5.26%
EPS Q2Q-119.32%
Number of Analysts12
Next Earnings Revisions
Revenue (1 Month)
-1.84%
Revenue (3 Months)
-3.16%
EPS (1 Month)
-112.68%
EPS (3 Months)
-111.95%
Next Earnings Summary
CC is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.03 USD and the consensus revenue estimate is 1.44B USD.
The next earnings revenue estimate has been revised downward by 3.16% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.078B -10.54% | 5.782B -4.87% | 5.808B 0.45% | 6.216B 7.02% | 6.515B 4.81% | 6.848B 5.11% | |
| EBITDA YoY % growth | 215M -80.07% | 736M 242.33% | 335M -54.48% | 874M 160.90% | 1.009B 15.45% | 1.102B 9.22% | |
| EBIT YoY % growth | -92M -111.68% | 435M 572.83% | -5M -101.15% | 536.84M 10,836.80% | 671.48M 25.08% | 751.95M 11.98% | |
| Operating Margin | -1.51% | 7.52% | -0.09% | 8.64% | 10.31% | 10.98% | |
| EPS YoY % growth | 3.02 -34.20% | 1.21 -59.93% | 0.96 -20.66% | 1.78 85.34% | 2.44 36.90% | 3.23 32.78% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.03 -119.32% | 0.67 14.90% | 0.64 222.13% | 0.34 582.68% | 0.31 1,330.52% | 0.80 20.56% | 0.84 31.10% | 0.38 11.65% |
| Revenue Q2Q % growth | 1.44B 5.26% | 1.688B 4.52% | 1.615B 8.03% | 1.433B 7.74% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 148.18M -14.84% | 280.16M 4,102.29% | 265.04M -25.76% | 208.3M -38.55% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 68.979M -19.79% | 191.73M 202.53% | 184.34M 88.10% | 124.2M 12,520.00% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
49.91%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
4.65%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
36.61%
EBIT Next 5 Year
N/A
CHEMOURS CO/THE / CC Forecast FAQ
Can you provide the average price target for CHEMOURS CO/THE stock?
18 analysts have analysed CC and the average price target is 19 USD. This implies a price increase of 13.42% is expected in the next year compared to the current price of 16.75.
When does CHEMOURS CO/THE (CC) report earnings?
CHEMOURS CO/THE (CC) will report earnings on 2026-05-04.
What are the consensus estimates for CC stock next earnings?
The consensus EPS estimate for the next earnings of CHEMOURS CO/THE (CC) is -0.03 USD and the consensus revenue estimate is 1.44B USD.
Can you provide the expected long term growth rate for CHEMOURS CO/THE stock?
The expected long term growth rate for CHEMOURS CO/THE (CC) is 4.65%.